K Kurz1, R Voelker, D Zdunek, R Wergeland, G Hess, B Ivandic, H Katus, E Giannitsis. 1. Abteilung Innere Medizin III, Medizinische Klinik, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany, and Institute of Clinical Chemistry, Rikshospitalet, Oslo, Norway. Kerstin.Kurz@med.uni-heidelberg.de
Abstract
OBJECTIVE: There is controversy whether new biomarkers are able to identify myocardial ischemia in the absence of myonecrosis. METHOD: We measured NT-pro BNP, NT-pro ANP, ischemia-modified albumin (IMA) and placental growth factor (PlGF) in patients undergoing nuclear stress testing for suspected ischemic heart disease. A thallium scan was used for detection of reversible myocardial ischemia and cardiac troponin T (cTnT) for exclusion of stress-induced myonecrosis. Of 195 patients, 24 with reversible and 62 with no perfusion defect were included in the analysis. Plasma levels were measured before, 18 min and 4 h after stress testing. RESULTS: Of the 86 patients, 52 received an exercise stress and 34 dipyridamol. New myonecrosis indicated by cTnT could be excluded in all patients. Plasma levels of NT-pro BNP and NT-pro ANP before testing were significantly higher in patients who later developed reversible perfusion defects (NT-pro BNP 139.00 (58.25/367.01) pg/mL vs 327.45 (120.50/972.85) pg/mL, p<0.05; NT-pro ANP 732.5 (470.0/1220.0) pg/mL vs 1470.0 (694.0/1910.0) pg/mL, p<0.05). Plasma levels of NT-pro BNP, NT-pro ANP and PIGF did not change significantly after stress testing, IMA levels rose significantly after 4 h in patients with and without reversible perfusion defects. CONCLUSION: The elevation of NTpro BNP and NT-pro ANP at baseline may represent the cumulative effect of repeated bouts of myocardial ischemia. A single brief episode of provoked ischemia does not cause a significant increase of the measured biomarkers beside from IMA after exercise stress test potentially indicating skeletal muscle ischemia.
OBJECTIVE: There is controversy whether new biomarkers are able to identify myocardial ischemia in the absence of myonecrosis. METHOD: We measured NT-pro BNP, NT-pro ANP, ischemia-modified albumin (IMA) and placental growth factor (PlGF) in patients undergoing nuclear stress testing for suspected ischemic heart disease. A thallium scan was used for detection of reversible myocardial ischemia and cardiac troponin T (cTnT) for exclusion of stress-induced myonecrosis. Of 195 patients, 24 with reversible and 62 with no perfusion defect were included in the analysis. Plasma levels were measured before, 18 min and 4 h after stress testing. RESULTS: Of the 86 patients, 52 received an exercise stress and 34 dipyridamol. New myonecrosis indicated by cTnT could be excluded in all patients. Plasma levels of NT-pro BNP and NT-pro ANP before testing were significantly higher in patients who later developed reversible perfusion defects (NT-pro BNP 139.00 (58.25/367.01) pg/mL vs 327.45 (120.50/972.85) pg/mL, p<0.05; NT-pro ANP 732.5 (470.0/1220.0) pg/mL vs 1470.0 (694.0/1910.0) pg/mL, p<0.05). Plasma levels of NT-pro BNP, NT-pro ANP and PIGF did not change significantly after stress testing, IMA levels rose significantly after 4 h in patients with and without reversible perfusion defects. CONCLUSION: The elevation of NTpro BNP and NT-pro ANP at baseline may represent the cumulative effect of repeated bouts of myocardial ischemia. A single brief episode of provoked ischemia does not cause a significant increase of the measured biomarkers beside from IMA after exercise stress test potentially indicating skeletal muscle ischemia.
Authors: Charlotte Kragelund; Bjørn Grønning; Lars Køber; Per Hildebrandt; Rolf Steffensen Journal: N Engl J Med Date: 2005-02-17 Impact factor: 91.245
Authors: J A de Lemos; D A Morrow; J H Bentley; T Omland; M S Sabatine; C H McCabe; C Hall; C P Cannon; E Braunwald Journal: N Engl J Med Date: 2001-10-04 Impact factor: 91.245
Authors: H Yasue; M Yoshimura; H Sumida; K Kikuta; K Kugiyama; M Jougasaki; H Ogawa; K Okumura; M Mukoyama; K Nakao Journal: Circulation Date: 1994-07 Impact factor: 29.690
Authors: Marc S Sabatine; David A Morrow; James A de Lemos; Torbjorn Omland; Milind Y Desai; Milenko Tanasijevic; Christian Hall; Carolyn H McCabe; Eugene Braunwald Journal: J Am Coll Cardiol Date: 2004-11-16 Impact factor: 24.094
Authors: Roman Pfister; Thorsten Wahlers; Frank M Baer; Max Scherner; Justus Strauch; Erland Erdmann Journal: Clin Res Cardiol Date: 2010-02-06 Impact factor: 5.460
Authors: Mikko Haapio; Andrew A House; Massimo de Cal; Dinna N Cruz; Paolo Lentini; Davide Giavarina; Antonio Fortunato; Luigi Menghetti; Matteo Salgarello; Andrea Lupi; Giuliano Soffiati; Alessandro Fontanelli; Pierluigi Zanco; Claudio Ronco Journal: Int J Nephrol Date: 2010-10-20
Authors: Ronald J Torry; Robert J Tomanek; Wei Zheng; Steven J Miller; Carlos A Labarrere; Donald S Torry Journal: J Heart Lung Transplant Date: 2009-02 Impact factor: 10.247
Authors: M Başkurt; F Aktürk; K Keskin; P Canbolat; B Karadag; A Kaya; A Yildiz; U Coskun; K Kilickesmez; O Esen; S K Muniboglu Journal: Cardiovasc J Afr Date: 2011 Mar-Apr Impact factor: 1.167
Authors: Alexander T Limkakeng; J Clancy Leahy; S Michelle Griffin; Yuliya Lokhnygina; Elias Jaffa; Robert H Christenson; L Kristin Newby Journal: Open Heart Date: 2018-10-08